Physician profile
David Shephard
NPI 1700087350
$13,379.06
in general payments reported to CMS, 2019-2025
16 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,185 · 2020: $365 · 2021: $2,390 · 2022: $497 · 2023: $3,737 · 2024: $755 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,798 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,925 · Travel and Lodging: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,798.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,925.00 |
| Travel and Lodging | $1,217.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,690.12 | 2019-2025 | Mako, Triathlon, Inspace |
| Heron Therapeutics, INC. | $2,252.00 | 2021-2023 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $1,048.77 | 2019 | |
| Depuy Synthes Sales INC. | $76.74 | 2021-2023 | Monovisc |
| Ortho Development Corporation | $50.66 | 2024 | |
| Baxter Healthcare | $32.35 | 2024 | Floseal |
| Abbott Laboratories | $30.51 | 2024 | Proclaim |
| Merck Sharp & Dohme LLC | $29.87 | 2021-2023 | Bridion |
| Kite Pharma, INC. | $29.14 | 2025 | Yescarta |
| Pacira Therapeutics, INC. | $27.16 | 2019 | |
| Baudax Bio INC. | $22.76 | 2021 | |
| Covidien Lp | $21.44 | 2019 | |
| Bioventus LLC | $20.77 | 2024 | Bioness Integrated System (Bits)2.0.5 |
| Ferring Pharmaceuticals INC. | $18.05 | 2019 | |
| Biocomposites INC | $16.81 | 2025 | Stimulan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shephard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.